Fresenius Kabi
Lucas Leake possesses extensive experience in leadership and investigation within the healthcare and quality improvement sectors. Currently serving as Director at Fresenius Kabi since May 2018, Lucas previously held the position of Investigator with the Department of Health and Human Services from August 2008 to May 2018. Prior to this, Lucas contributed to quality improvement initiatives at PepsiCo from January 2005 to August 2008. Lucas holds a degree from Northern Arizona University, completed between 1998 and 2003.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.